What's Behind Pacific Biosciences of California's Stock Rally Today?
Shares of Pacific Biosciences of California (NASDAQ: PACB) are on the rise again. This is the third trading session in a row that the stock has marched upwards since announcing record revenues and a big order for its next-generation genomic sequencers last week. The stock has tacked on a 11.7% gain as of 2:45 p.m. EDT on Monday.
The stock has risen about 40% since Aug. 2. After the bell that afternoon, Pacific Biosciences announced a new agreement with genomic services giant Novogene. The latter company agreed to double its Sequel-driven sequencing capacity with a purchase of 10 more systems.
Image source: Getty Images.
Source: Fool.com
Pacific Biosciences of California Inc. Stock
€1.71
1.700%
Our community is currently high on Pacific Biosciences of California Inc. with 10 Buy predictions and 5 Sell predictions.
Based on the current price of 1.71 € the target price of 10 € shows a potential of 484.86% for Pacific Biosciences of California Inc. which would more than double the current price.
